| Hematogenous metastasis of ovarian cancer: rethinking mode of spread S Pradeep, SW Kim, SY Wu, M Nishimura, P Chaluvally-Raghavan, ... Cancer cell 26 (1), 77-91, 2014 | 339 | 2014 |
| Autocrine effects of tumor-derived complement MS Cho, HG Vasquez, R Rupaimoole, S Pradeep, S Wu, B Zand, HD Han, ... Cell reports 6 (6), 1085-1095, 2014 | 206 | 2014 |
| Role of focal adhesion kinase in regulating YB–1–mediated paclitaxel resistance in ovarian cancer Y Kang, W Hu, C Ivan, HJ Dalton, T Miyake, CV Pecot, B Zand, T Liu, ... Journal of the National Cancer Institute 105 (19), 1485-1495, 2013 | 183 | 2013 |
| 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity SY Wu, X Yang, KM Gharpure, H Hatakeyama, M Egli, MH McGuire, ... Nature communications 5 (1), 3459, 2014 | 128 | 2014 |
| A case of disseminated peritoneal leiomyomatosis developing after laparoscope-assisted myomectomy T Miyake, T Enomoto, Y Ueda, K Ikuma, E Morii, S Matsuzaki, Y Murata Gynecologic and obstetric investigation 67 (2), 96-102, 2009 | 90 | 2009 |
| PIK3CA gene mutations and amplifications in uterine cancers, identified by methods that avoid confounding by PIK3CA pseudogene sequences T Miyake, K Yoshino, T Enomoto, T Takata, H Ugaki, A Kim, K Fujiwara, ... Cancer letters 261 (1), 120-126, 2008 | 79 | 2008 |
| Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma K Matsuo, Y Takazawa, MS Ross, E Elishaev, I Podzielinski, M Yunokawa, ... Annals of oncology 27 (7), 1257-1266, 2016 | 78 | 2016 |
| Notch3 pathway alterations in ovarian cancer W Hu, T Liu, C Ivan, Y Sun, J Huang, LS Mangala, T Miyake, HJ Dalton, ... Cancer research 74 (12), 3282-3293, 2014 | 76 | 2014 |
| DOCK2 is involved in the host genetics and biology of severe COVID-19 H Namkoong, R Edahiro, T Takano, H Nishihara, Y Shirai, K Sonehara, ... Nature 609 (7928), 754-760, 2022 | 53 | 2022 |
| Significance of lymphovascular space invasion in epithelial ovarian cancer K Matsuo, TB Sheridan, K Yoshino, T Miyake, KE Hew, DD Im, ... Cancer medicine 1 (2), 156-164, 2012 | 53 | 2012 |
| XPO1/CRM1 inhibition causes antitumor effects by mitochondrial accumulation of eIF5A T Miyake, S Pradeep, SY Wu, R Rupaimoole, B Zand, Y Wen, ... Clinical Cancer Research 21 (14), 3286-3297, 2015 | 46 | 2015 |
| Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer KM Gharpure, KS Chu, CJ Bowerman, T Miyake, S Pradeep, SL Mangala, ... Molecular cancer therapeutics 13 (7), 1750-1757, 2014 | 44 | 2014 |
| Postpartum outcome of cervical intraepithelial neoplasia in pregnant women determined by route of delivery Y Ueda, T Enomoto, T Miyatake, K Yoshino, M Fujita, T Miyake, ... Reproductive Sciences 16, 1034-1039, 2009 | 44 | 2009 |
| Application of deep learning to the classification of uterine cervical squamous epithelial lesion from colposcopy images combined with HPV types Y Miyagi, K Takehara, Y Nagayasu, T Miyake Oncology letters 19 (2), 1602-1610, 2020 | 43 | 2020 |
| Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer NM Reusser, HJ Dalton, S Pradeep, V Gonzalez-Villasana, NB Jennings, ... Cancer biology & therapy 15 (8), 1061-1067, 2014 | 43 | 2014 |
| Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma K Matsuo, K Omatsu, MS Ross, MS Johnson, M Yunokawa, ... Gynecologic oncology 145 (1), 78-87, 2017 | 41 | 2017 |
| Application of deep learning to the classification of uterine cervical squamous epithelial lesion from colposcopy images Y Miyagi, K Takehara, T Miyake Molecular and clinical oncology 11 (6), 583-589, 2019 | 40 | 2019 |
| Targeting SRC and tubulin in mucinous ovarian carcinoma T Liu, W Hu, HJ Dalton, HJ Choi, J Huang, Y Kang, S Pradeep, T Miyake, ... Clinical Cancer Research 19 (23), 6532-6543, 2013 | 40 | 2013 |
| CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma T Miyake, Y Ueda, S Matsuzaki, T Miyatake, K Yoshino, M Fujita, ... Journal of cancer research and clinical oncology 137, 715-722, 2011 | 40 | 2011 |
| Frequent inactivation of RUNX3 in endometrial carcinoma T Yoshizaki, T Enomoto, M Fujita, Y Ueda, T Miyatake, K Fujiwara, ... Gynecologic oncology 110 (3), 439-444, 2008 | 33 | 2008 |
